Outcome in Adult Bronchiectasis

The outcome in adult bronchiectasis has not been well described; in particular there has been a lack of long-term prospective studies. Therefore a follow-up study was performed to assess outcome in bronchiectasis in a cohort of adult patients. One hundred-and-one sequential adults, 33 male and 68 female; age 54 ± 14 years (mean ± SD) with bronchiectasis had a clinical assessment and spirometry performed. All were non-smokers and 84 were classified as having idiopathic disease. Patients were commenced on a standardized treatment regime and followed up for a minimum period of 2 years. On their last review when patients were clinically stable, a repeat clinical assessment and spirometry was performed and compared with the initial review. The primary endpoints measured were symptoms and FEV1. Subjects were followed up for 8.0 ± 4.9 years. Clinical review showed that the patients had persistent symptoms that, in the case of dyspnea and sputum volume, were worse on follow-up. Spirometry showed a significant decline in FEV1 over the follow-up period with an average loss of 49 ml per year. This study showed in this group of predominantly female adult patients with bronchiectasis followed up for 8 years, patients had persistent symptoms and an excess loss in FEV1.

[1]  J. Wedzicha,et al.  Airway bacterial load and FEV1 decline in patients with chronic obstructive pulmonary disease. , 2003, American journal of respiratory and critical care medicine.

[2]  Moira Chan-Yeung,et al.  High-resolution CT quantification of bronchiectasis: clinical and functional correlation. , 2002, Radiology.

[3]  M. Chan-yeung,et al.  Validation of the Hong Kong Chinese version of the St. George Respiratory Questionnaire in patients with bronchiectasis. , 2002, Chest.

[4]  L. Sharples,et al.  A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic , 2002, Health technology assessment.

[5]  M. Greenstone,et al.  Prolonged antibiotics for purulent bronchiectasis. , 2002, The Cochrane database of systematic reviews.

[6]  M. Greenstone,et al.  Inhaled hyperosmolar agents for bronchiectasis. , 2002, The Cochrane database of systematic reviews.

[7]  R. Rodríguez-Roisín,et al.  Bacterial colonisation in patients with bronchiectasis: microbiological pattern and risk factors , 2002, Thorax.

[8]  J. Wedzicha.  Airway infection accelerates decline of lung function in chronic obstructive pulmonary disease. , 2001, American journal of respiratory and critical care medicine.

[9]  M. Keogan,et al.  An investigation into causative factors in patients with bronchiectasis. , 2000, American journal of respiratory and critical care medicine.

[10]  R. Lutter,et al.  Airway inflammation in nonobstructive and obstructive chronic bronchitis with chronic haemophilus influenzae airway infection. Comparison with noninfected patients with chronic obstructive pulmonary disease. , 2000, American journal of respiratory and critical care medicine.

[11]  R. Stockley,et al.  Relationship of sputum color to nature and outpatient management of acute exacerbations of COPD. , 2000, Chest.

[12]  D. Hansell,et al.  Airflow obstruction in bronchiectasis: correlation between computed tomography features and pulmonary function tests , 2000, Thorax.

[13]  K. Yuen,et al.  Inhaled fluticasone reduces sputum inflammatory indices in severe bronchiectasis. , 1998, American journal of respiratory and critical care medicine.

[14]  A. O'donnell,et al.  Treatment of idiopathic bronchiectasis with aerosolized recombinant human DNase I. rhDNase Study Group. , 1998, Chest.

[15]  I. D. Johnston,et al.  Effect of pneumonia and whooping cough in childhood on adult lung function. , 1998, The New England journal of medicine.

[16]  J. Powles,et al.  The Australian mortality decline: cause‐specific mortality 1907–1990 , 1998, Australian and New Zealand journal of public health.

[17]  S. Kivelä,et al.  Bronchiectasis: an orphan disease with a poorly-understood prognosis. , 1997, The European respiratory journal.

[18]  P. Jones,et al.  Validation of the St. George's Respiratory Questionnaire in bronchiectasis. , 1997, American journal of respiratory and critical care medicine.

[19]  J. Vestbo,et al.  Association of chronic mucus hypersecretion with FEV1 decline and chronic obstructive pulmonary disease morbidity. Copenhagen City Heart Study Group. , 1996, American journal of respiratory and critical care medicine.

[20]  L. Fabbri,et al.  Airways obstruction, chronic expectoration, and rapid decline of FEV1 in smokers are associated with increased levels of sputum neutrophils. , 1996, Thorax.

[21]  M. Nicotra,et al.  Clinical, pathophysiologic, and microbiologic characterization of bronchiectasis in an aging cohort. , 1995, Chest.

[22]  D M Hansell,et al.  CT findings in bronchiectasis: limited value in distinguishing between idiopathic and specific types. , 1995, AJR. American journal of roentgenology.

[23]  J. Elborn,et al.  Inhaled steroids in patients with bronchiectasis. , 1992, Respiratory medicine.

[24]  E. Bardana,et al.  Bronchiectasis: update of an orphan disease. , 1988, The American review of respiratory disease.

[25]  J. Bloom,et al.  The course and prognosis of different forms of chronic airways obstruction in a sample from the general population. , 1987, The New England journal of medicine.

[26]  P. Thornley,et al.  Present outlook in bronchiectasis: clinical and social study and review of factors influencing prognosis. , 1981, Thorax.

[27]  R. Peto,et al.  The natural history of chronic airflow obstruction. , 1977, British medical journal.

[28]  N. S. Clark.  Bronchiectasis in Childhood , 1963, British medical journal.

[29]  Field Ce.  Bronchiectasis: A Long-term Follow-up of Medical and Surgical Cases from Childhood , 1961 .

[30]  D. J. Conway.  Bronchiectasis in Childhood , 1952, Postgraduate medical journal.

[31]  C. E. Field.  Bronchiectasis in childhood; clinical survey of 160 cases. , 1949, Pediatrics.

[32]  L. Sharples,et al.  A randomised controlled crossover trial of nurse practitioner versus doctor led outpatient care in a bronchiectasis clinic. , 2002, Thorax.

[33]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[34]  M. Hodson,et al.  Changes in spirometry during consecutive admissions for infective pulmonary exacerbations in adolescent and adult cystic fibrosis. , 1992, Respiratory medicine.

[35]  Phillips Yy,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. This official statement of the American Thoracic Society was adopted by the ATS Board of Directors, November 1986. , 1987, The American review of respiratory disease.

[36]  B. Burrows,et al.  Course and prognosis of chronic obstructive lung disease. A prospective study of 200 patients. , 1969, The New England journal of medicine.

[37]  C. E. Field.  Bronchiectasis. A long-term follow-up of medical and surgical cases from childhood. , 1961, Archives of disease in childhood.